Boston Partners’s Arcosa ACA Stock Holding History

Boston Partners’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1M	Sell	36,899 -6,764	-15%	-$769K	﹤0.01%	639
2025 Q4	$1.86M	Buy	43,663 +790	+2%	+$79.8K	﹤0.01%	570
2025 Q3	$1.98M	Buy	42,873 +9,084	+27%	+$845K	﹤0.01%	566
2025 Q2	$2.93M	Sell	33,789 -26,743	-44%	-$2.24M	﹤0.01%	511
2025 Q1	$4.67M	Sell	60,532 -109,855	-64%	-$10.1M	0.01%	440
2024 Q4	$16.5M	Sell	170,387 -130,727	-43%	-$13.1M	0.02%	349
2024 Q3	$28.5M	Sell	301,114 -45,870	-13%	-$4.01M	0.03%	288
2024 Q2	$29M	Buy	346,984 +126,023	+57%	+$10.5M	0.04%	280
2024 Q1	$18.9M	Buy	220,961 +161,662	+273%	+$13.2M	0.02%	333
2023 Q4	$4.9M	Sell	59,299 -35,530	-37%	-$2.61M	0.01%	421
2023 Q3	$6.82M	Sell	94,829 -9,667	-9%	-$733K	0.01%	396
2023 Q2	$7.92M	Buy	104,496 +14,622	+16%	+$983K	0.01%	389
2023 Q1	$5.67M	Buy	89,874 +81,633	+991%	+$4.79M	0.01%	391
2022 Q4	$448K	Buy	+8,241	New	+$489K	﹤0.01%	608

Other funds holding ACA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Boston Partners's ACA Position: Q1 2026 in Review

Boston Partners reduced its Arcosa (ACA) stake by 15% in Q1 2026, selling an estimated $769K and leaving 36,899 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #639.

Boston Partners first reported a position in ACA in Q4 2022 and has held it in 14 quarters since. The position peaked at $29M in Q2 2024. 372 funds tracked by Wall St. Rank hold ACA as of Q1 2026.

Boston Partners held 36,899 shares of Arcosa worth $1M as of Q1 2026.
Boston Partners sold 6,764 Arcosa shares in Q1 2026, an estimated $769K.
Arcosa made up ﹤0.01% of Boston Partners's portfolio in Q1 2026, its #639 holding.
Boston Partners first reported a position in Arcosa in Q4 2022 and has held it in 14 quarters since.
Boston Partners's Arcosa position peaked at $29M in Q2 2024.
372 funds tracked by Wall St. Rank held Arcosa as of Q1 2026.

Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.